| 國立政治大學 |
2009 |
Laminin B1抑制ERK1/2及SGK1的活化進而抑制大白鼠空間記憶的形成
|
劉文婷 |
| 國家衛生研究院 |
2018-11-28 |
Laminin gamma2-enriched extracellular vesicles of oral squamous cell carcinoma cells enhance in vitro lymphangiogenesis via intergrin alpha3-dependent uptake by lymphatic endothelial cells
|
Wang, SH;Liou, GG;Liu, SH;Chang, JS;Hsiao, JR;Yen, YC;Chen, YL;Wu, WL;Chang, JY;Chen, YW |
| 國家衛生研究院 |
2016-10 |
Laminin modification subretinal bio-scaffold remodels retinal pigment epithelium-driven microenvironment in vitro and in vivo
|
Peng, CH;Chuang, JH;Wang, ML;Jhan, YY;Chien, KH;Chung, YC;Hung, KH;Chang, CC;Lee, CK;Tseng, WL;Hwang, DK;Hsu, CH;Lin, TC;Chiou, SH;Chen, SJ |
| 國立交通大學 |
2017-04-21T06:55:52Z |
Laminin modification subretinal bio-scaffold remodels retinal pigment epithelium-driven microenvironment in vitro and in vivo
|
Peng, Chi-Hsien; Chuang, Jen-Hua; Wang, Mong-Lien; Jhan, Yong-Yu; Chien, Ke-Hung; Chung, Yu-Chien; Hung, Kuo-Hsuan; Chang, Chia-Ching; Lee, Chao-Kuei; Tseng, Wei-Lien; Hwang, De-Kuang; Hsu, Chia-Hsien; Lin, Tai-Chi; Chiou, Shih-Hwa; Chen, Shih-Jen |
| 國立成功大學 |
2016-06-03 |
Laminin Receptor in Shrimp Is a Cellular Attachment Receptor for White Spot Syndrome Virus
|
Liu, Wang-Jing; Li, Yi-Chieh; Kou, Guang-Hsiung; Lo, Chu-Fang |
| 臺北市立大學 |
2016-06 |
Laminin receptor in shrimp is a cellular attachment receptor for white spot syndrome virus (蝦類層粘連蛋白受體為白點症病毒細胞附著受體)
|
劉宛菁(地球環境暨生物資源學系) |
| 國立成功大學 |
2019 |
Laminin γ2-enriched extracellular vesicles of oral squamous cell carcinoma cells enhance in vitro lymphangiogenesis via integrin α3-dependent uptake by lymphatic endothelial cells
|
Wang, S.-H.;Liou, G.-G.;Liu, S.-H.;Chang, J.S.;Hsiao, J.-R.;Yen, Yen Y.-C.;Chen, Y.-L.;Wu, Wu W.-L.;Chang, J.-Y.;Chen, Y.-W. |
| 國家衛生研究院 |
2017-03 |
Laminin-alginate beads as preadipocyte carriers to enhance adipogenesis in vitro and in vivo
|
Hsueh, YS;Chen, YS;Tai, HC;Mestak, O;Chao, SC;Chen, YY;Shih, Y;Lin, JF;Shieh, MJ;Lin, FH |
| 臺大學術典藏 |
2020-02-26T01:32:51Z |
Laminin-Alginate Beads as Preadipocyte Carriers to Enhance Adipogenesis in Vitro and in Vivo
|
Hsueh, Y.-S.;Chen, Y.-S.;Tai, H.-C.;Mestak, O.;Chao, S.-C.;Chen, Y.-Y.;Shih, Y.;Lin, J.-F.;Shieh, M.-J.;Lin, F.-H.Feng-Huei Lin; Hsueh, Y.-S.; Chen, Y.-S.; Tai, H.-C.; Mestak, O.; Chao, S.-C.; Chen, Y.-Y.; Shih, Y.; Lin, J.-F.; Shieh, M.-J.; Lin, F.-H.; FENG-HUEI LIN |
| 臺大學術典藏 |
2020-06-17T03:00:31Z |
Laminin-Alginate Beads as Preadipocyte Carriers to Enhance Adipogenesis in Vitro and in Vivo
|
Hsueh Y.-S.;Chen Y.-S.;Hao-Chih Tai;Mestak O.;Chao S.-C.;Chen Y.-Y.;Shih Y.;Lin J.-F.;Shieh M.-J.;Lin F.-H.; Hsueh Y.-S.; Chen Y.-S.; HAO-CHIH TAI; Mestak O.; Chao S.-C.; Chen Y.-Y.; Shih Y.; Lin J.-F.; Shieh M.-J.; Lin F.-H. |
| 臺大學術典藏 |
2022-02-08T03:44:36Z |
Laminin-Alginate Beads as Preadipocyte Carriers to Enhance Adipogenesis In Vitro and In Vivo
|
Hsueh, Yu-Sheng; Chen, Yo-Shen; Tai, Hao-Chih; Mestak, Ondrej; SUNG-CHUAN CHAO; Chen, Yen-Yu; Shih, Ying; Lin, Jung-Feng; Shieh, Ming-Jium; Lin, Feng-Huei |
| 臺大學術典藏 |
2020-02-27T06:39:24Z |
Laminin-Alginate Beads as Preadipocyte Carriers to Enhance Adipogenesis in Vitro and in Vivo
|
Hsueh Y.-S.;Chen Y.-S.;Tai H.-C.;Mestak O.;Chao S.-C.;Chen Y.-Y.;Shih Y.;Lin J.-F.;Ming-Jium Shieh;Lin F.-H.; Hsueh Y.-S.; Chen Y.-S.; Tai H.-C.; Mestak O.; Chao S.-C.; Chen Y.-Y.; Shih Y.; Lin J.-F.; MING-JIUM SHIEH; Lin F.-H. |
| 國立臺灣海洋大學 |
2007-06-15 |
Laminin-incorporated nerve conduits made by plasma treatment for repairing spinal cord injury
|
Henrich Cheng;Yi-Cheng Huang;Pei-Teh Chang;Yi-You Huang |
| 國立臺灣大學 |
2007 |
Laminin-incorporated nerve conduits made by plasma treatment for repairing spinal cord injury
|
Cheng, Henrich; Huang, Yi-Cheng; Chang, Pei-Teh; Huang, Yi-You |
| 臺大學術典藏 |
2020-02-27T03:16:02Z |
Laminin-incorporated nerve conduits made by plasma treatment for repairing spinal cord injury
|
Cheng H; Huang Y.-C; Chang P.-T; YI-YOU HUANG; Cheng H;Huang Y.-C;Chang P.-T;Yi-You Huang |
| 國立臺灣海洋大學 |
2011 |
Laminin-modified conduit for nerve regeneration and methods of manufacturing the conduit and regenerating nerves using the conduit.
|
黃意真; Yi-Cheng Huang |
| 國立臺灣大學 |
1996 |
Laminins Promote the Locomotion of Skeletal Myoblasts Via the Alpha 7 Integrin Receptor
|
姚宗珍; YAO, CHUNG-CHEN |
| 臺大學術典藏 |
1996 |
Laminins promote the locomotion of skeletal myoblasts via the alpha 7 integrin receptor
|
Kramer R.H.; Mendrick D.L.; Sutherland A.E.; Ziober B.L.; JANE CHUNG-CHEN YAO; Jane Chung-Chen Yao;Ziober B.L.;Sutherland A.E.;Mendrick D.L.;Kramer R.H. |
| 國立臺灣大學 |
1996 |
Laminins promote the locomotion of skeletal myoblasts via the alpha 7 integrin receptor. [Journal Article. Research Support, U.S. Gov’t, P.H.S.]
|
Yao, C.C.; Ziober, B.L.; Sutherland, A.E.; Mendrick, D.L.; Kramer, R.H. |
| 慈濟大學 |
2004 |
Laminin的個別功能區域對於調節內皮細胞移行與血管新生的作用
|
黃靜宜 |
| 臺大學術典藏 |
2009 |
Lamivudine and hepatitis B reactivation
|
CHIUN HSU; Cheng A.-L.; Chen P.-J. |
| 臺大學術典藏 |
2020-04-10T12:51:21Z |
Lamivudine and hepatitis B reactivation
|
Chiun Hsu; Cheng A.-L.; Chen P.-J. |
| 臺大學術典藏 |
2021-07-03T03:34:50Z |
Lamivudine and hepatitis B reactivation
|
Hsu C.; Cheng A.-L.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-09-01T01:54:20Z |
Lamivudine and hepatitis B reactivation
|
Hsu C.; ANN-LII CHENG; Chen P.-J. |
| 中國醫藥大學 |
2002 |
Lamivudine does not increase the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B
|
Yang, SS; Hsu, CT; Hu, JT; Lai, YC; Wu, CH |
| 國立臺灣大學 |
2004 |
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
|
廖運範; 李嘉哲; LIAW, YUN-FAN; SUNG JOSEPH J.Y.; CHOW WAN-CHENG; GEOFFREY FARRELL; LEE, CHA-ZE; YUEN HON; TAWESAK TANWANDEE; TAO QI-MIN; KELLY SHUE; OLIVER N. KEENE; JONATHAN S. DIXON; D. FRASER GRAY; JAN SABBAT |
| 臺大學術典藏 |
2021-02-02T07:51:01Z |
Lamivudine for patients with chronic hepatitis B and advanced liver disease
|
Liaw Y.-F.; Sung J.J.Y.; Chow W.C.; Farrell G.; Lee, Cha-Ze; Yuen H.; Tanwandee T.; Tao Q.-M.; Shue K.; Keene O.N.; Dixon J.S.; Gray D.F.; Sabbat J. |
| 臺大學術典藏 |
2018-09-10T07:27:25Z |
Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: A multicentre, randomized, double-blind, placebo-controlled study
|
Xu, W.-M.;Cui, Y.-T.;Wang, L.;Yang, H.;Liang, Z.-Q.;Li, X.-M.;Zhang, S.-L.;Qiao, F.-Y.;Campbell, F.;Chang, C.-N.;Gardner, S.;Atkins, M.; HUNG-CHIH YANG |
| 臺大學術典藏 |
2018-09-10T03:23:08Z |
Lamivudine treatment for hbv infection in patients receiving hematopoietic stem cell transplantation in ntuh
|
Lee, C.C. and Yao, M. and Lai, M. and Tang, J.L. and Chen, Y.C.; YEE-CHUN CHEN |
| 臺大學術典藏 |
2021-01-06T03:58:59Z |
Lamivudine treatment for hbv infection in patients receiving hematopoietic stem cell transplantation in ntuh
|
Lee C.C.; Yao M.; Lai M.; JIH-LUH TANG; Chen Y.C. |
| 臺大學術典藏 |
2018-09-10T03:41:08Z |
Lamivudine treatment for hepatitis B reactivation in HBsAg carriers after organ transplantation: A 4-year experience
|
Liu, C.-J.;Lai, M.-Y.;Lee, P.-H.;Chou, N.-K.;Chu, S.-H.;Chen, P.-J.;Kao, J.-H.;Jen, Y.-M.;Chen, D.-S.Po-Huang Lee;Nai-Kuan Chou;Chun-Jen Liu;Pei-Jer Chen;Ding-Shinn Chen;Jia-Horng Kao; Liu, C.-J.; Lai, M.-Y.; Lee, P.-H.; Chou, N.-K.; Chu, S.-H.; Chen, P.-J.; Kao, J.-H.; Jen, Y.-M.; Chen, D.-S. |
| 國立臺灣大學 |
2001 |
Lamivudine Treatment for Hepatitis B Reactivation in Hbsag Carriers after Organ Transplantation: A 4-Year Experience
|
劉俊人; 李伯皇; 陳定信; 賴明陽; LIU, CHUN-JEN; LEE, PO-HUANG; CHEN, DING-SHINN; LAI, MING-YANG |
| 臺大學術典藏 |
2020-03-09T07:31:18Z |
Lamivudine treatment for hepatitis B reactivation in HBsAg carriers after organ transplantation: A 4-year experience
|
Liu C.-J.;Lai M.-Y.;Lee P.-H.;Nai-Kuan Chou;Chu S.-H.;Chen P.-J.;Kao J.-H.;Jen Y.-M.;Chen D.-S.; Liu C.-J.; Lai M.-Y.; Lee P.-H.; NAI-KUAN CHOU; Chu S.-H.; Chen P.-J.; Kao J.-H.; Jen Y.-M.; Chen D.-S. |
| 臺大學術典藏 |
2020-11-19T03:43:09Z |
Lamivudine treatment for hepatitis B reactivation in HBsAg carriers after organ transplantation: A 4-year experience
|
Liu C.-J.;Lai M.-Y.;Po-Huang Lee;Chou N.-K.;Chu S.-H.;Chen P.-J.;Kao J.-H.;Jen Y.-M.;Chen D.-S.; Liu C.-J.; Lai M.-Y.; PO-HUANG LEE; Chou N.-K.; Chu S.-H.; Chen P.-J.; Kao J.-H.; Jen Y.-M.; Chen D.-S. |
| 臺大學術典藏 |
2021-07-03T03:35:50Z |
Lamivudine treatment for hepatitis B reactivation in HBsAg carriers after organ transplantation: A 4-year experience
|
Liu C.-J.; Lai M.-Y.; Lee P.-H.; Chou N.-K.; Chu S.-H.; PEI-JER CHEN; Kao J.-H.; Jen Y.-M.; Chen D.-S. |
| 臺大學術典藏 |
2022-01-24T09:32:30Z |
Lamivudine treatment for hepatitis B reactivation in HBsAg carriers after organ transplantation: A 4-year experience
|
CHUN-JEN LIU; Lai M.-Y.; Lee P.-H.; Chou N.-K.; Chu S.-H.; Chen P.-J.; Kao J.-H.; Jen Y.-M.; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T06:19:19Z |
Lamivudine treatment for hepatitis B reactivation in HBsAg carriers after organ transplantation: A 4-year experience
|
Liu C.-J.; Lai M.-Y.; Lee P.-H.; Chou N.-K.; Chu S.-H.; Chen P.-J.; JIA-HORNG KAO; Jen Y.-M.; Chen D.-S. |
| 國立臺灣大學 |
2010 |
Lamivudine Treatment in Infantile Fulminant Hepatitis B
|
陳靖宜; 倪衍玄; 陳慧玲; 呂立; 張美惠; CHEN, CHING-YI; NI, YEN-HSUAN; CHEN, HUEY-LING; LU, FRANK LEIGH; CHANG, MEI-HWEI |
| 臺大學術典藏 |
2010 |
Lamivudine treatment in infantile fulminant hepatitis B
|
Chang M.-H.; Lu F.L.; HUEY-LING CHEN; Ni Y.-H.; Chen C.-Y.; Chen C.-Y.;Ni Y.-H.;Huey-Ling Chen;Lu F.L.;Chang M.-H. |
| 臺大學術典藏 |
2020-12-08T03:28:53Z |
Lamivudine treatment in infantile fulminant hepatitis B
|
Chen C.-Y.;Ni Y.-H.;Chen H.-L.;Frank Leigh Lu;Chang M.-H.; Chen C.-Y.; Ni Y.-H.; Chen H.-L.; FRANK LEIGH LU; Chang M.-H. |
| 臺大學術典藏 |
2020-12-28T08:14:34Z |
Lamivudine treatment in infantile fulminant hepatitis B
|
Lu F.L.; Chen H.-L.; YEN-HSUAN NI; Chen C.-Y.; Chang M.-H. |
| 臺大學術典藏 |
2021-01-04T07:33:53Z |
Lamivudine treatment in infantile fulminant hepatitis B
|
Chen C.-Y.;Ni Y.-H.;Chen H.-L.;Lu F.L.;Mei-Hwei Chang; Chen C.-Y.; Ni Y.-H.; Chen H.-L.; Lu F.L.; MEI-HWEI CHANG |
| 國立臺灣大學 |
2005-08 |
Lamivudine treatment in maternally transmitted chronic hepatitis B virus infection patients
|
Ni, YH; Huang, FC; Wu, TC; Kong, MS; Jeng, YM; Chen, PJ; Tsuei, DJ; Chen, HL; Hsu, HY; Chang, MH |
| 臺大學術典藏 |
2018-09-10T05:22:23Z |
Lamivudine treatment in maternally transmitted chronic hepatitis B virus infection patients
|
Ni, Y.-H. and Huang, F.-C. and Wu, T.-C. and Kong, M.-S. and Jeng, Y.-M. and Chen, P.-J. and Tsuei, D.-J. and Chen, H.-L. and Hsu, H.-Y. and Chang, M.-H.; HONG-YUAN HSU; MEI-HWEI CHANG; PEI-JER CHEN; YUNG-MING JENG; Yen-Hsuan Ni |
| 臺大學術典藏 |
2019-12-25T04:04:25Z |
Lamivudine treatment in maternally transmitted chronic hepatitis B virus infection patients
|
Ni Y.-H.;Huang F.-C.;Wu T.-C.;Kong M.-S.;Jeng Y.-M.;Chen P.-J.;Tsuei D.-J.;Chen H.-L.;Hong-Yuan Hsu;Chang M.-H.; Ni Y.-H.; Huang F.-C.; Wu T.-C.; Kong M.-S.; Jeng Y.-M.; Chen P.-J.; Tsuei D.-J.; Chen H.-L.; HONG-YUAN HSU; Chang M.-H. |
| 臺大學術典藏 |
2020-03-06T08:25:36Z |
Lamivudine treatment in maternally transmitted chronic hepatitis B virus infection patients
|
Ni Y.-H.;Huang F.-C.;Wu T.-C.;Kong M.-S.;Yung-Ming Jeng;Chen P.-J.;Tsuei D.-J.;Chen H.-L.;Hsu H.-Y.;Chang M.-H.; Ni Y.-H.; Huang F.-C.; Wu T.-C.; Kong M.-S.; YUNG-MING JENG; Chen P.-J.; Tsuei D.-J.; Chen H.-L.; Hsu H.-Y.; Chang M.-H. |
| 臺大學術典藏 |
2005 |
Lamivudine treatment in maternally transmitted chronic hepatitis B virus infection patients
|
Ni Y.-H.;Huang F.-C.;Wu T.-C.;Kong M.-S.;Jeng Y.-M.;Chen P.-J.;Tsuei D.-J.;Huey-Ling Chen;Hsu H.-Y.;Chang M.-H.; Ni Y.-H.; Huang F.-C.; Chang M.-H.; Wu T.-C.; Kong M.-S.; Jeng Y.-M.; Chen P.-J.; Tsuei D.-J.; HUEY-LING CHEN; Hsu H.-Y. |
| 臺大學術典藏 |
2005 |
Lamivudine treatment in maternally transmitted chronic hepatitis B virus infection patients
|
Yen-Hsuan Ni;Huang F.-C.;Wu T.-C.;Kong M.-S.;Jeng Y.-M.;Chen P.-J.;Tsuei D.-J.;Chen H.-L.;Hsu H.-Y.;Chang M.-H.; YEN-HSUAN NI; Huang F.-C.; Wu T.-C.; Kong M.-S.; Jeng Y.-M.; Chen P.-J.; Tsuei D.-J.; Chen H.-L.; Hsu H.-Y.; Chang M.-H. |
| 臺大學術典藏 |
2021-01-04T07:36:18Z |
Lamivudine treatment in maternally transmitted chronic hepatitis B virus infection patients
|
Hsu H.-Y.; MEI-HWEI CHANG; Ni Y.-H.;Huang F.-C.;Wu T.-C.;Kong M.-S.;Jeng Y.-M.;Chen P.-J.;Tsuei D.-J.;Chen H.-L.;Hsu H.-Y.;Mei-Hwei Chang; Ni Y.-H.; Huang F.-C.; Wu T.-C.; Kong M.-S.; Jeng Y.-M.; Chen P.-J.; Tsuei D.-J.; Chen H.-L. |
| 臺大學術典藏 |
2021-07-03T03:35:23Z |
Lamivudine treatment in maternally transmitted chronic hepatitis B virus infection patients
|
Ni Y.-H.; Huang F.-C.; Wu T.-C.; Kong M.-S.; Jeng Y.-M.; PEI-JER CHEN; Tsuei D.-J.; Chen H.-L.; Hsu H.-Y.; Chang M.-H. |
